The dynactin p150 subunit: cell biology studies of sequence changes found in ALS/MND and Parkinsonian Syndromes

The dynactin p150glued subunit, encoded by the gene DCTN1 is part of the dynein–dynactin motor protein complex responsible for retrograde axonal transport. This subunit is a candidate modifier for neurodegenerative diseases, in particular motoneuron and extrapyramidal diseases. Based on an extensive...

Full description

Saved in:
Bibliographic Details
Published in:Journal of Neural Transmission Vol. 120; no. 5; pp. 785 - 798
Main Authors: Stockmann, Marianne, Meyer-Ohlendorf, Marie, Achberger, Kevin, Putz, Stefan, Demestre, Maria, Yin, Haishan, Hendrich, Corinna, Linta, Leonhard, Heinrich, Jutta, Brunner, Cornelia, Proepper, Christian, Kuh, Georges F., Baumann, Bernd, Langer, Torben, Schwalenstöcker, Birgit, Braunstein, Kerstin E., von Arnim, Christine, Schneuwly, Stephan, Meyer, Thomas, Wong, Philip C., Boeckers, Tobias M., Ludolph, Albert C., Liebau, Stefan
Format: Journal Article
Language:English
Published: Vienna Springer Vienna 01-05-2013
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The dynactin p150glued subunit, encoded by the gene DCTN1 is part of the dynein–dynactin motor protein complex responsible for retrograde axonal transport. This subunit is a candidate modifier for neurodegenerative diseases, in particular motoneuron and extrapyramidal diseases. Based on an extensive screening effort of all 32 exons in more than 2,500 ALS/MND patients, patients suffering from Parkinsonian Syndromes and controls, we investigated 24 sequence variants of p150 in cell-based studies. We used both non-neuronal cell lines and primary rodent spinal motoneurons and report on cell biological abnormalities in five of these sequence alterations and also briefly report on the clinical features. Our results suggest the presence of biological changes caused by some p150 mutants pointing to a potential pathogenetic significance as modifier of the phenotype of the human disease.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0300-9564
1435-1463
DOI:10.1007/s00702-012-0910-z